Polyphyllin VII increases sensitivity to gefitinib by modulating the elevation of P21 in acquired gefitinib resistant non-small cell lung cancer

Polyphyllin VII increases sensitivity to gefitinib by modulating the elevation of P21 in acquired gefitinib resistant non-small cell lung cancer

Blockade of EGFR with reversible EGFR tyrosine kinase inhibitors (TKIs) is considered the frontline strategy for advanced NSCLC with EGFR mutations. However, acquired resistance to EGFR-TKI has been observed, resulting in disease progression and limited clinical benefit. Polyphyllin VII is the main...

Полное описание

Библиографические подробности
Главные авторы: Honggang Wang, Zhenghua Fei, Hao Jiang
Формат: Статья
Язык:English
Опубликовано: Elsevier 2017-07-01
Серии:Journal of Pharmacological Sciences
Предметы:
P21
Acquired resistance
NSCLC
Polyphyllin
Cell cycle
Online-ссылка:http://www.sciencedirect.com/science/article/pii/S1347861317300919

Internet

http://www.sciencedirect.com/science/article/pii/S1347861317300919

Схожие документы